GlaxoSmithKline LLC v. Banner Pharmacaps Inc.
1:11-cv-00046
Overview
Parties
Defendant
Roxane Laboratories Inc. Operating Company
Represented By
4 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Watson Laboratories Inc. - Florida Operating Company
Represented By
8 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Counter Claimant
Watson Pharma Inc. Operating Company
Represented By
3 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Watson Pharmaceuticals Inc. Operating Company
Represented By
2 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 5,565,467 A Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 5,846,976 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 12,328,093 A | US Continuation / Sibling | View Official Patent → |
GlaxoSmithKline LLC v. Apotex Inc.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5565467
Androstenone derivative
|
Filed: 1995-03-16
Issued: 1996-10-15
|
Expired (Term Ended)
+249d PTA
Expires: 2015-11-20
|
|
|
US5846976
Androstenone derivative
|
Filed: 1996-08-22
Issued: 1998-12-08
|
Expired (Term Ended)
Expires: 2016-08-22
|
|
|
US5998427
Androstenones
|
Filed: 1998-05-14
Issued: 1999-12-07
|
Expired (Term Ended)
Expires: 2018-05-14
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+249 days) / Cellect Scrutiny — Over 249 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
21
Dispositive
0
Granted
0
Denied
1
Pending / Review
20
Motions by Category
Key Dispositive Motions & Rulings